K. Ryan

发表

Trends in medical use and abuse of opioid analgesics.

J. L. Dahl, A. Gilson, D. Joranson, 2000, JAMA.

PBMC telomerase activity in depression and the response to electroconvulsive therapy

D. McLoughlin, K. Ryan, M. Finnegan, 2021, European Archives of Psychiatry and Clinical Neuroscience.

Tryptophan metabolite concentrations in depressed patients before and after electroconvulsive therapy

D. McLoughlin, K. Ryan, K. Allers, 2020, Brain, Behavior, and Immunity.

Peripheral blood GILZ mRNA levels in depression and following electroconvulsive therapy

D. McLoughlin, K. Ryan, 2019, Psychoneuroendocrinology.

Low Circulating Levels of GR, FKBP5, and SGK1 in Medicated Patients With Depression Are Not Altered by Electroconvulsive Therapy

D. McLoughlin, K. Ryan, Lena Poelz, 2019, The journal of ECT.

Peripheral blood E2F1 mRNA in depression and following electroconvulsive therapy

D. McLoughlin, K. Ryan, E. Kolshus, 2019, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

BDNF plasma levels and genotype in depression and the response to electroconvulsive therapy

D. McLoughlin, K. Ryan, R. Dunne, 2018, Brain Stimulation.

Vascular endothelial growth factor plasma levels in depression and following electroconvulsive therapy

D. McLoughlin, K. Ryan, 2018, European Archives of Psychiatry and Clinical Neuroscience.

Acute phase plasma proteins are altered by electroconvulsive stimulation

M. Dunn, S. O’Mara, D. McLoughlin, 2014, Journal of psychopharmacology.

Microglia and their LAG3 checkpoint underlie the antidepressant and neurogenesis-enhancing effects of electroconvulsive stimulation

D. McLoughlin, K. Ryan, R. Refaeli, 2021, Molecular Psychiatry.

Progress to Achieve Balanced State Policy Relevant to Pain Management and Palliative Care

A. Gilson, D. Joranson, K. Ryan, 2005, Journal of pain & palliative care pharmacotherapy.

Ensuring opioid availability: methods and resources.

D. Joranson, K. Ryan, 2007, Journal of pain and symptom management.

Dexamethasone attenuates inflammatory-mediated suppression of β2-adrenoceptor expression in rat primary mixed glia

T. Connor, K. Ryan, A. Harkin, 2019, Journal of Neuroimmunology.

A Bibliography of Recent Pharmaceutical Care Articles on Pain Management and End-of-Life Care Issues

A. Gilson, K. Ryan, Martha A. Mauer, 2000 .

Peripheral blood inflammatory markers in depression: Response to electroconvulsive therapy and relationship with cognitive performance

D. McLoughlin, K. Ryan, 2022, Psychiatry Research.

Medical Use and Abuse of Opioids

A. Gilson, D. Joranson, K. Ryan, 2000 .

Peripheral blood SIRT1 mRNA levels in depression and treatment with electroconvulsive therapy

D. McLoughlin, K. Ryan, M. Finnegan, 2019, European Neuropsychopharmacology.

Peripheral blood SIRT1 mRNA levels in depression and treatment with electroconvulsive therapy

D. McLoughlin, K. Ryan, M. Finnegan, 2018, European Neuropsychopharmacology.

A Multifaceted Approach to Improve the Availability and Accessibility of Opioids for the Treatment of Cancer Pain in Serbia: Results From the International Pain Policy Fellowship (2006-2012) and Recommendations for Action.

J. Cleary, K. Ryan, Ivana Popović, 2016, Journal of pain and symptom management.

Whole blood mitochondrial DNA copy number in depression and response to electroconvulsive therapy

D. McLoughlin, K. Ryan, E. Doody, 2022, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Vascular endothelial growth factor and pigment epithelial-derived factor in the peripheral response to ketamine.

D. McLoughlin, K. Ryan, C. McGrory, 2020, Journal of affective disorders.

Blood cell ratios in mood and cognitive outcomes following electroconvulsive therapy.

D. McLoughlin, K. Ryan, M. Lynch, 2022, Journal of psychiatric research.

Multivariate analysis of countries’ government and health-care system influences on opioid availability for cancer pain relief and palliative care: More than a function of human development

Virginia T. LeBaron, J. Cleary, A. Gilson, 2013, Palliative medicine.

Ensuring Patient Access to Essential Medicines While Minimizing Harmful Use: A Revised World Health Organization Tool to Improve National Drug Control Policy

J. Cleary, A. Gilson, K. Ryan, 2011, Journal of pain & palliative care pharmacotherapy.

Pain management and prescription monitoring.

Grant M. Carrow, J. L. Dahl, A. Gilson, 2002, Journal of pain and symptom management.

Blood plasma B vitamins in depression and the therapeutic response to electroconvulsive therapy

D. McLoughlin, K. Ryan, K. Allers, 2020, Brain, behavior, & immunity - health.

Electroconvulsive stimulation alters levels of BDNF-associated microRNAs

D. McLoughlin, K. Ryan, S. O’Donovan, 2013, Neuroscience Letters.

Stimulation of central β2-adrenoceptors suppresses NFκB activity in rat brain: A role for IκB

K. Ryan, T. Connor, É. Griffin, 2013, Neurochemistry International.

Stimulation of central b2-adrenoceptors suppresses NFjB activity in rat brain: A role for IjB

K. Ryan, T. Connor, K. Ryan, 2013 .

Peroxisome proliferator-activated receptor gamma co-activator-1 alpha in depression and the response to electroconvulsive therapy

D. McLoughlin, K. Ryan, I. Patterson, 2018, Psychological Medicine.

Telomere length in patients with anorexia nervosa

D. McLoughlin, K. Ryan, Eimear Doody MRCPsych, 2022, Psychiatry Research Communications.

Telomere length in depression and association with therapeutic response to electroconvulsive therapy and cognitive side-effects

D. McLoughlin, K. Ryan, 2019, Psychological Medicine.

Clenbuterol activates the central IL-1 system via the β2-adrenoceptor without provoking inflammatory response related behaviours in rats

K. Ryan, T. Connor, É. Griffin, 2016, Brain, Behavior, and Immunity.

Reform of drug control policy for palliative care in Romania

D. Joranson, K. Ryan, Jody P Garthwaite, 2006, The Lancet.

A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002.

J. L. Dahl, A. Gilson, D. Joranson, 2004, Journal of pain and symptom management.

Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: implications for depression and neurodegeneration.

T. Connor, K. Ryan, N. Curtin, 2009, The international journal of neuropsychopharmacology.

The Pain & Policy Studies Group International Program

K. Ryan, Karen M. Ryan, 2007, Journal of pain & palliative care pharmacotherapy.

Noradrenaline acting at β-adrenoceptors induces expression of IL-1β and its negative regulators IL-1ra and IL-1RII, and drives an overall anti-inflammatory phenotype in rat cortex

K. Ryan, T. Connor, É. Griffin, 2010, Neuropharmacology.

Noradrenaline induces IL-1ra and IL-1 type II receptor expression in primary glial cells and protects against IL-1beta-induced neurotoxicity.

Dana Kilroy, T. Connor, K. Ryan, 2010, European journal of pharmacology.

Noradrenaline acting at central β-adrenoceptors induces interleukin-10 and suppressor of cytokine signaling-3 expression in rat brain: Implications for neurodegeneration

K. Ryan, T. Connor, R. González-Reyes, 2010, Brain, Behavior, and Immunity.

Electroconvulsive Stimulation in Rats Induces Alterations in the Hippocampal miRNome: Translational Implications for Depression

A. Sartorius, G. Blackshields, O. Sheils, 2022, Molecular Neurobiology.

Opioid availability and palliative care in Nepal: influence of an international pain policy fellowship.

E. Krakauer, J. Cleary, K. Ryan, 2015, Journal of pain and symptom management.

Using a morphine equivalence metric to quantify opioid consumption: examining the capacity to provide effective treatment of debilitating pain at the global, regional, and country levels.

P. Rathouz, J. Cleary, A. Gilson, 2013, Journal of pain and symptom management.

Ketamine for depression relapse prevention following electroconvulsive therapy: protocol for a randomised pilot trial (the KEEP-WELL trial)

L. Daly, D. McLoughlin, K. Ryan, 2016, Pilot and Feasibility Studies.

Improving the availability and accessibility of opioids for the treatment of pain: The International Pain Policy Fellowship

K. Ryan, S. Bošnjak, M. León, 2011, Supportive Care in Cancer.

▪ Opioid Policy, Availability, and Access in Developing and Nonindustrialized Countries

D. Joranson, K. Ryan, Martha A Maurer, 2010 .

Improving availability of and access to opioids in Colombia: description and preliminary results of an action plan for the country.

L. de Lima, K. Ryan, M. León, 2009, Journal of pain and symptom management.

Italy reforms national policy for cancer pain relief and opioids.

D. Joranson, K. Ryan, C. Blengini, 2003, European journal of cancer care.

Noradrenaline reuptake inhibitors inhibit expression of chemokines IP-10 and RANTES and cell adhesion molecules VCAM-1 and ICAM-1 in the CNS following a systemic inflammatory challenge

T. Connor, K. Ryan, A. Harkin, 2010, Journal of Neuroimmunology.

Peripheral blood microRNA and VEGFA mRNA changes following electroconvulsive therapy: implications for psychotic depression

G. Blackshields, O. Sheils, D. McLoughlin, 2017, Acta psychiatrica Scandinavica.

Ketamine Versus Midazolam for Depression Relapse Prevention Following Successful Electroconvulsive Therapy: A Randomized Controlled Pilot Trial.

L. Daly, D. McLoughlin, K. Ryan, 2018, The journal of ECT.

Interrogating Associations between Polygenic Liabilities and Electroconvulsive Therapy Effectiveness

M. Arns, P. V. Eijndhoven, B. Baune, 2022, Biological Psychiatry.

Electroconvulsive therapy modulates plasma pigment epithelium-derived factor in depression: a proteomics study

M. Dunn, D. McLoughlin, A. Glaviano, 2017, Translational Psychiatry.

From molecules to mind: mechanisms of action of electroconvulsive therapy

K. Ryan, D. Mcloughlin, 2018, Acta psychiatrica Scandinavica.

PARP1 and OGG1 in Medicated Patients With Depression and the Response to ECT

D. McLoughlin, K. Ryan, 2022, The international journal of neuropsychopharmacology.

When less is more – microRNAs and psychiatric disorders

D. McLoughlin, D. McLoughlin, K. Ryan, 2014, Acta psychiatrica Scandinavica.

Integrating palliative care in public health: The Colombian experience following an International Pain Policy Fellowship

L. de Lima, K. Ryan, M. León, 2011, Palliative medicine.

Noradrenaline acting at β-adrenoceptors induces expression of IL-1β and its negative regulators IL-1ra and IL-1RII, and drives an overall anti-inflammatory phenotype in rat cortex

K. Ryan, T. Connor, É. Griffin, 2010, Neuropharmacology.

Noradrenaline reuptake inhibitors inhibit expression of chemokines IP-10 and RANTES and cell adhesion molecules VCAM-1 and ICAM-1 in the CNS following a systemic inflammatory challenge

T. Connor, K. Ryan, A. Harkin, 2010, Journal of Neuroimmunology.